Leading experts in cytometry science, laboratory medicine, and cancer research from the University of Pennsylvania, New York Blood Center, and Amgen strengthen Nodexus’ scientific leadership

SAN JOSE, Calif.–(BUSINESS WIRE)–Nodexus Inc., a leader in automated benchtop single-cell characterization and microfluidic isolation technologies, today announced that three leading experts in cytometry sciences, pathology, and cancer biology have joined its Scientific Advisory Board (SAB). The Nodexus SAB is chaired by Professor Jonni Moore, PhD, one of the world’s leading experts in flow cytometry, laboratory medicine, and cellular immunology.

The SAB will provide strategic direction and guidance for commercial expansion and product innovation to help Nodexus on its mission to accelerate cell biology workflows and make them universally accessible. Nodexus’ NX One single-cell isolation system is quickly emerging as a critical component for cell line and antibody development, CRISPR and protein engineering, synthetic biology, and single-cell genomics, among other rapidly growing applications, and the company’s SAB aims to accelerate further adoption of Nodexus platforms.

“We are excited to have some of the world’s foremost experts in cytometry join our SAB, and we are confident that the breadth of knowledge that Jonni, John, and Peter bring to Nodexus will enable us to drive innovation for single-cell workflows,” said Karthik Balakrishnan, PhD, Founder and CEO of Nodexus. “With the support of our SAB, we’re dedicated to providing advanced capabilities and value to scientists – all at a price that every lab can afford. Our stellar group of scientific advisors will lead us in providing transformational advancements in cell biology.”

Read full article on businesswire.com